Inge H Briaire-de Bruijn Selected Research

Inge H Briaire-de Bruijn Research Topics

Disease

11	Neoplasms (Cancer) 01/2023 - 12/2004
8	Chondrosarcoma 01/2023 - 08/2009
3	Myxoid Liposarcoma 01/2020 - 04/2015
2	Chondroma (Enchondroma) 11/2020 - 01/2017
2	Colorectal Neoplasms (Colorectal Cancer) 01/2020 - 08/2009
2	Glioma (Gliomas) 12/2019 - 05/2015
2	Leiomyosarcoma 01/2019 - 01/2018
2	Synovial Sarcoma (Synovioma) 01/2019 - 04/2015
2	Osteosarcoma (Osteogenic Sarcoma) 01/2017 - 05/2013
1	Chordoma 01/2024
1	Giant Cell Tumors (Giant Cell Tumor) 09/2022
1	Bone Cysts (Bone Cyst) 12/2021
1	Breast Neoplasms (Breast Cancer) 01/2020
1	Ovarian Neoplasms (Ovarian Cancer) 01/2020
1	Cholangiocarcinoma 01/2020
1	Leukemia 12/2019
1	Ataxia Telangiectasia (Louis Bar Syndrome) 12/2019
1	Sarcoma (Soft Tissue Sarcoma) 01/2019
1	Osteoblastoma 01/2017
1	Mesenchymal Chondrosarcoma 10/2016
1	Smooth Muscle Tumor 11/2015
1	Pheochromocytoma 11/2015
1	Paraganglioma (Paragangliomas) 11/2015
1	Esophageal Squamous Cell Carcinoma 04/2015
1	Testicular Neoplasms (Testicular Cancer) 04/2015
1	Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor) 08/2010
1	Myxoma (Myxomas) 07/2009
1	Fibroma (Fibromatosis) 01/2006
1	Enchondromatosis (Ollier Disease) 12/2004

Drug/Important Bio-Agent (IBA)

5	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 01/2023 - 05/2015
4	Biomarkers (Surrogate Marker)IBA 01/2019 - 01/2017
2	talazoparibIBA 01/2023 - 12/2019
2	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 01/2023 - 12/2019
2	AlginatesIBA 01/2023 - 01/2020
2	Poly(ADP-ribose) Polymerase InhibitorsIBA 01/2023 - 12/2019
2	Temozolomide (Temodar)FDA LinkGeneric 01/2023 - 12/2019
2	Histone Deacetylase InhibitorsIBA 09/2022 - 01/2019
2	RNA (Ribonucleic Acid)IBA 11/2020 - 01/2017
2	alpha-hydroxyglutarateIBA 11/2020 - 12/2019
2	Polysaccharides (Glycans)IBA 01/2020 - 01/2016
2	ParaffinIBA 01/2017 - 12/2015
2	histone H3 trimethyl Lys4IBA 01/2017 - 11/2015
2	DNA (Deoxyribonucleic Acid)IBA 01/2017 - 11/2015
2	Succinate Dehydrogenase (Fumarate Reductase)IBA 01/2017 - 11/2015
2	Formaldehyde (Formol)FDA Link 01/2017 - 12/2015
2	Fumarate Hydratase (Fumarase)IBA 01/2017 - 11/2015
2	5-hydroxymethylcytosineIBA 01/2017 - 11/2015
2	Messenger RNA (mRNA)IBA 05/2013 - 07/2009
1	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 12/2021
1	A-Form DNA (A-DNA)IBA 11/2020
1	Histone Deacetylases (Histone Deacetylase)IBA 11/2020
1	Small Interfering RNA (siRNA)IBA 11/2020
1	sapanisertibIBA 01/2020
1	Mannose (D-Mannose)IBA 01/2020
1	MethyltransferasesIBA 12/2019
1	AGI-5198IBA 01/2019
1	SurvivinIBA 01/2019
1	Macrophage Colony-Stimulating FactorIBA 01/2018
1	ChromatinIBA 01/2017
1	MicroRNAs (MicroRNA)IBA 01/2017
1	ABT-737IBA 10/2016
1	Histones (Histone)IBA 11/2015
1	Tricarboxylic AcidsIBA 11/2015
1	EnzymesIBA 11/2015
1	AntigensIBA 04/2015
1	Somatomedin Receptors (Somatomedin Receptor)IBA 05/2013
1	3- (8- amino- 1- (2- phenylquinolin- 7- yl)imidazo(1,5- a)pyrazin- 3- yl)- 1- methylcyclobutanolIBA 05/2013
1	Tyrosine Kinase InhibitorsIBA 08/2010
1	Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA 08/2009
1	Imatinib Mesylate (Gleevec)FDA Link 08/2009
1	Dasatinib (BMS 354825)FDA Link 08/2009
1	Peptides (Polypeptides)IBA 08/2009
1	Phosphotransferases (Kinase)IBA 08/2009
1	DecorinIBA 07/2009
1	CollagenIBA 07/2009
1	Proteins (Proteins, Gene)FDA Link 07/2009
1	Transforming Growth Factor beta1 (TGF beta 1)IBA 01/2006
1	OligonucleotidesIBA 12/2004
1	Type 1 Parathyroid Hormone Receptor (Parathyroid Hormone Receptor)IBA 12/2004

Therapy/Procedure

5	Radiotherapy 01/2023 - 08/2009
3	Immunotherapy 01/2024 - 04/2015
3	Drug Therapy (Chemotherapy) 01/2023 - 08/2009
2	Therapeutics 01/2020 - 01/2019
1	Duration of Therapy 01/2023
1	Lasers (Laser) 01/2020